Peer Review reports
From: Computationally repurposing drugs for breast cancer subtypes using a network-based approach
| Original Submission | ||
|---|---|---|
| 25 Jun 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 10 Sep 2021 | Reviewed | Reviewer Report |
| 14 Sep 2021 | Reviewed | Reviewer Report |
| 4 Oct 2021 | Reviewed | Reviewer Report |
| 16 Jan 2022 | Author responded | Author comments - Luis Rueda |
| Resubmission - Version 4 | ||
| 16 Jan 2022 | Submitted | Manuscript version 4 |
| 26 Jan 2022 | Author responded | Author comments - Luis Rueda |
| Resubmission - Version 5 | ||
| 26 Jan 2022 | Submitted | Manuscript version 5 |
| 16 Feb 2022 | Reviewed | Reviewer Report |
| 17 Feb 2022 | Reviewed | Reviewer Report |
| 25 Feb 2022 | Reviewed | Reviewer Report |
| 24 Mar 2022 | Author responded | Author comments - Luis Rueda |
| Resubmission - Version 6 | ||
| 24 Mar 2022 | Submitted | Manuscript version 6 |
| Publishing | ||
| 30 Mar 2022 | Editorially accepted | |
| 20 Apr 2022 | Article published | 10.1186/s12859-022-04662-6 |
You can find further information about peer review here.